Skip to main content
ZYME logo
ZYME
(NASDAQ)
Zymeworks Inc.
$23.12-- (--)
Loading... - Market loading

Zymeworks (ZYME) Stock Price & Financial Analysis

Zymeworks Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$22.86 - $23.51
52-Week High$29.75
52-Week Low$11.51
Open$22.98
Volume327.33K
Average Volume (3M)599.76K
Market Cap1.73B
Shares Outstanding74.69M
Price to Sales (P/S)21.25
Price to Book (P/B)10.56
EV/EBITDA-15.12
Revenue (TTM)81.26M
Net Income (TTM)-102.66M
Free Cash Flow (TTM)-77.12M
EPS (TTM)$-1.35
Profit Margin-126.33%
Operating Margin-140.29%
Return on Equity (ROE)-62.75%
Debt to Equity0.10
50-Day MA$24.44
200-Day MA$23.82
52-Week Change61.79%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Zymeworks

What is the current stock price for ZYME?

As of the latest trading session, ZYME stock trades at $23.12. The 52-week range is $11.51–$29.75, with a day range of $22.86–$23.51.

What is the P/E ratio for ZYME?

The P/E ratio (Price-to-Earnings) for ZYME is shown in the Key Statistics section. This valuation metric helps compare Zymeworks Inc. to industry peers.

Does ZYME pay dividends?

Zymeworks does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ZYME?

Based on 9 analysts, the consensus for ZYME is Buy.

What is the market cap of ZYME?

Zymeworks's market capitalization is $1.73B, classifying it as a small-cap company. Zymeworks operates in the Healthcare sector within the Biotechnology industry.